[1] Wisplinghoff H,Bischoff T,Tallent SM,et al.Nosocomial bloodstream infections in US hospitals:analysis of 24 179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309-317. [2] Wilson LS,Reyes CM,Stolpman M,et al.The direct cost and incidence of systemic fungal infections[J].Value Health,2002,5 (1):26-34. [3] Wenzel RP.Nosocomial candidemia:risk factors and attributable mortality[J].Clin Infect Dis,1995,20(6):1531-1534. [4] Aperis G,Myriounis N,Spanakis E,et al.Developments in the treatment of candidissis:more choices and new challenges[J].Exp Opin Investig Drags,2006,15 (11):1319-1336. [5] Neeraj Chauhan,Jean-PanL Large,Richard Calderone.Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus[J].Nat Microbiol Rev,2006,4(4):435-444. [6] Michael Kruppa,Richard Calderone.Two-component signal transduction in humanfungal pathogens[J].FEMS Yeast Res,2006,6(2):149-159. [7] Mascher T,Heintz M,Zahner D,et al.The CiaBH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance[J].J Bacteriol,2006,188 (5):1959-1968. [8] Sharma K,Gupta M,Pathak M,et al.Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein,EmbR,in vivo[J].J Bacteriol,2006,188 (8):2936-2944. [9] National Commttee for clinical laboratory standards.2002.Rference method for broth dilution antifungai susceptibility testing of yeasts.Approved standard M27-A2,2nd ed.National committee for clinical laboratory standards,Wayne,PA. [10] Arthington-Skaggs BA,Jradi H,Desai T,et al.Quantitation of ergosterol content:novel method for determination of fluconazole susceptibility of Candida albicans[J].J Clin Microbiol,1999,37 (10):3332-3337. [11] Chauhan N,Inglis D,Roman E,et al.The SSK1 of Candida albicans is associated with oxidative stress adaptation and cell wall biosynthesis[J].Euk Cell,2003,2(5):1018-1024. [12] Chen Du,Richard Calderone,John Richert,et al.Deletion of the SSK1 response reguLator gene in Candida albicans contributes to enhanced killing by human polymorphonuclear neutrophils[J].Infect Immun,2005,73(2):865-871. [13] Jose' Antonio Calera,Xiaojiong Zhao,Richard Calderone.Defecfive hyphal development and avirulence caused by a deletion of the SSK1 response reguLator gene in Candida albicans[J].Infect Immun,2000,68(2):518-525. |